Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells.
Carracedo A, Lorente M, Egia A, Blázquez C, García S, Giroux V, Malicet C, Villuendas R, Gironella M, González-Feria L, Piris MA, Iovanna JL, Guzmán M, Velasco G. Carracedo A, et al. Among authors: Blazquez C. Cancer Cell. 2006 Apr;9(4):301-12. doi: 10.1016/j.ccr.2006.03.005. Cancer Cell. 2006. PMID: 16616335
Hypothesis: cannabinoid therapy for the treatment of gliomas?
Velasco G, Galve-Roperh I, Sánchez C, Blázquez C, Guzmán M. Velasco G, et al. Among authors: Blazquez C. Neuropharmacology. 2004 Sep;47(3):315-23. doi: 10.1016/j.neuropharm.2004.04.016. Neuropharmacology. 2004. PMID: 15275820 Review.
Sustained Gq-Protein Signaling Disrupts Striatal Circuits via JNK.
Bellocchio L, Ruiz-Calvo A, Chiarlone A, Cabanas M, Resel E, Cazalets JR, Blázquez C, Cho YH, Galve-Roperh I, Guzmán M. Bellocchio L, et al. Among authors: Blazquez C. J Neurosci. 2016 Oct 12;36(41):10611-10624. doi: 10.1523/JNEUROSCI.1192-16.2016. J Neurosci. 2016. PMID: 27733612 Free PMC article.
MicroRNA let-7d is a target of cannabinoid CB1 receptor and controls cannabinoid signaling.
Chiarlone A, Börner C, Martín-Gómez L, Jiménez-González A, García-Concejo A, García-Bermejo ML, Lorente M, Blázquez C, García-Taboada E, de Haro A, Martella E, Höllt V, Rodríguez R, Galve-Roperh I, Kraus J, Guzmán M. Chiarlone A, et al. Among authors: Blazquez C. Neuropharmacology. 2016 Sep;108:345-52. doi: 10.1016/j.neuropharm.2016.05.007. Epub 2016 May 11. Neuropharmacology. 2016. PMID: 27179908
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease.
Blázquez C, Chiarlone A, Sagredo O, Aguado T, Pazos MR, Resel E, Palazuelos J, Julien B, Salazar M, Börner C, Benito C, Carrasco C, Diez-Zaera M, Paoletti P, Díaz-Hernández M, Ruiz C, Sendtner M, Lucas JJ, de Yébenes JG, Marsicano G, Monory K, Lutz B, Romero J, Alberch J, Ginés S, Kraus J, Fernández-Ruiz J, Galve-Roperh I, Guzmán M. Blázquez C, et al. Brain. 2011 Jan;134(Pt 1):119-36. doi: 10.1093/brain/awq278. Epub 2010 Oct 7. Brain. 2011. PMID: 20929960
Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.
Blázquez C, Salazar M, Carracedo A, Lorente M, Egia A, González-Feria L, Haro A, Velasco G, Guzmán M. Blázquez C, et al. Cancer Res. 2008 Mar 15;68(6):1945-52. doi: 10.1158/0008-5472.CAN-07-5176. Cancer Res. 2008. PMID: 18339876
This cannabinoid-induced inhibition of MMP-2 expression in gliomas (a) was MMP-2-selective, as levels of other MMP family members were unaffected; (b) was mimicked by JWH-133, a CB(2) cannabinoid receptor-selective agonist that is devoid of psychoactive side effects; (c) was abrogated by fumonisin B1, a selective inhibitor of ceramide biosynthesis; and (d) was also evident in two patients with recurrent glioblastoma multiforme. ...
This cannabinoid-induced inhibition of MMP-2 expression in gliomas (a) was MMP-2-selective, as levels of other MMP family members were unaff …
Cannabinoids and gliomas.
Velasco G, Carracedo A, Blázquez C, Lorente M, Aguado T, Haro A, Sánchez C, Galve-Roperh I, Guzmán M. Velasco G, et al. Among authors: Blazquez C. Mol Neurobiol. 2007 Aug;36(1):60-7. doi: 10.1007/s12035-007-0002-5. Epub 2007 Jun 28. Mol Neurobiol. 2007. PMID: 17952650 Review.
Cannabinoid receptors as novel targets for the treatment of melanoma.
Blázquez C, Carracedo A, Barrado L, Real PJ, Fernández-Luna JL, Velasco G, Malumbres M, Guzmán M. Blázquez C, et al. FASEB J. 2006 Dec;20(14):2633-5. doi: 10.1096/fj.06-6638fje. Epub 2006 Oct 25. FASEB J. 2006. PMID: 17065222
65 results
Jump to page
Feedback